Catalyst
Slingshot members are tracking this event:
Phase 1/2 updated data of Fibrocell's (FCSC) FCX-007 in Recessive dystrophic epidermolysis bullosa due March 27, 2019.
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
FCSC | Community voting in process |
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 27, 2019
Occurred Source:
http://ir.fibrocell.com/phoenix.zhtml?c=253777&p=irol-newsArticle&ID=2392457
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Fcx-007, Recessive Dystrophic Epidermolysis Bullosa